Elevated plasma VWF levels have been associated with an increased atherothrombosis risk [1,2], while von Willebrand disease, characterized by low or defective VWF, is associated with a decreased risk of developing atherothrombosis [4,5]. Here, VWF is linked to platelet-type von Willebrand disease.